41608-64-4

Basic information

• Product Name: Methyl 4-amino-3-methoxybenzoate
• Synonyms: Benzoic acid, 4-aMino-3-Methoxy-, Methyl ester;3-METHOXY-4-AMINOBENZOIC ACID METHYL ESTER;4-AMINO-3-METHOXYBENZOIC ACID ETHYL ESTER;METHYL 3-METHOXY-4-AMINOBENZOATE;METHYL 4-AMINO-3-METHOXYBENZENECARBOXYLATE;METHYL 4-AMINO-3-METHOXYBENZOATE;Methyl 4-amino-3-methoxybenzoate 98%;4-Amino-3-methoxy benzoic acid methyl ester
• CAS NO: 41608-64-4
• Molecular Formula: C₉H₁₁NO₃
• Molecular Weight: 181.19
• EINECS: 255-456-5
• Product Categories: Benzene derivatives;Aromatic Esters
• Mol File: 41608-64-4.mol
• Article Data: 39

Chemical Properties

• Melting Point: 128-131°
• Boiling Point: 332 °C at 760 mmHg
• Flash Point: 175.4 °C
• Appearance: /
• Density: 1.179 g/cm³
• Vapor Pressure: 0.00015mmHg at 25°C
• Refractive Index: 1.55
• Storage Temp.: 2-8°C(protect from light)
• PKA: 2.41±0.10(Predicted)
• CAS DataBase Reference: Methyl 4-amino-3-methoxybenzoate(CAS DataBase Reference)
• NIST Chemistry Reference: Methyl 4-amino-3-methoxybenzoate(41608-64-4)
• EPA Substance Registry System: Methyl 4-amino-3-methoxybenzoate(41608-64-4)

Safety Data

• Hazard Codes: Xi,Xn
• Statements: 22
• HazardClass: IRRITANT
• Hazardous Substances Data: 41608-64-4(Hazardous Substances Data)

Usage

General Description

Methyl 4-amino-3-methoxybenzoate, also known as methyl 4-amino-3-methoxybenzoate, is a chemical compound with the molecular formula C9H11NO3. It is an ester derivative of 4-aminoveratrole and is commonly used in the pharmaceutical industry as an intermediate in the synthesis of various pharmaceuticals and organic compounds. It is a white crystalline solid with a slightly sweet odor and is soluble in organic solvents but insoluble in water. Methyl 4-amino-3-methoxybenzoate is also used as a flavoring agent and fragrance ingredient in cosmetic products. It is important to handle this compound with care as it may cause irritation to the skin, eyes, and respiratory system.

InChI:InChI=1/C9H11NO3/c1-12-8-5-6(9(11)13-2)3-4-7(8)10/h3-5H,10H2,1-2H3

Upstream product

• 5081-37-8 methyl 3-methoxy-4-nitrobenzoate 
• 2486-69-3 3-methoxy-4-aminobenzoic acid 
• 713-52-0 methyl 3-hydroxy-4-nitrobenzoate 
• 38512-82-2 3-methoxy-4-nitrotoluene 
• 67-56-1 methanol 
• 5368-81-0 methyl 3-methoxybenzoate 
• 5081-36-7 3-methoxy-4-nitrobenzoic acid 
• 619-14-7 3-hydroxy-4-nitro-benzoic acid 

Downstream Products

• 569344-23-6 methyl 4-amino-3-methoxy-5-methylthiomethylbenzoate 
• 74385-19-6 2-(4-Fluoro-3-methoxy-phenyl)-propan-2-ol 
• 74385-34-5 2,3-bis(4'-fluoro-3'-hydroxyphenyl)-2,3-dimethylbutane 
• 74385-26-5 2,3-bis(4'-fluoro-3'-methoxyphenyl)-2,3-dimethylbutane 
• 700834-18-0 4-formylamino-3-methoxybenzoic acid methyl ester 
• 1069130-64-8 methyl 3-methoxy-4-(4-methoxyphenylamino)benzoate 
• 1356588-31-2 C₂₅H₂₃N₅O₃ 
• 1069130-69-3 3-formyl-6-hydroxy-1-methoxy-9H-carbazole 
• 1384528-08-8 C₂₂H₁₉NO₅S 
• 1384528-10-2 3-chloromethyl-1-methoxy-9-tosyl-9H-carbazole 
• 1384528-09-9 C₂₁H₁₉NO₄S 
• 129598-18-1 Fe(CO)3(C₆H₇C₆H₂(NH₂)(OMe)COOMe) 
• 955886-84-7 methyl 2-amino-4-methoxy-1,3-benzothiazole-6-carboxylate 
• 1383740-05-3 methyl 2-chloro-4-methoxy-1,3-benzothiazole-6-carboxylate 

Relevant articles and documents

Total synthesis of inubosin B

Inubosin B is the most active member of the acridine alkaloids isolated from Streptomyces sp. IFM 11440 culture. The inubosins initiate neuroregeneration via a neurogenine 2 pathway. In this work, we have described the total synthesis of inubosin B via two synthetic routes. The effects of various coupling, cyclization and reduction reactions are discussed including common pitfalls and side reactions. Reverse phase chromatography with TFA was crucial for the isolation of the product from aluminum ions present in the reduction media.

NEW CLASS OF DNA GYRASE AND/OR TOPOISOMERASE IV INHIBITORS WITH ACTIVITY AGAINST GRAM-POSITIVE AND GRAM-NEGATIVE BACTERIA

The present invention relates to compounds having a structure of general formula (I), processes for their preparation, pharmaceutical compositions containing them as the active ingredient, to their use as medicaments and to their use in the manufacture of medicaments for use in the treatment of bacterial infections in humans and warm-blooded animals.

Spiroindolone polyethylene glycol carbonate compound, and compositions, preparation method and application thereof

The invention relates to a spiroindolone polyethylene glycol carbonate compound, compositions and a preparation method thereof, and an application of the spiroindolone polyethylene glycol carbonate compound as an anticancer drug due to antitumor activity of the spiroindolone polyethylene glycol carbonate compound. The spiroindolone polyethylene glycol carbonate compound has a structural formula asdescribed in the specification, has excellent tumor suppressive activity, good water solubility and low toxicity, and can be used for intravenous injections.